Legacy Advisors LLC lessened its stake in shares of UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 8.3% in the 1st quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 11,397 shares of the healthcare conglomerate's stock after selling 1,034 shares during the period. UnitedHealth Group accounts for approximately 0.6% of Legacy Advisors LLC's holdings, making the stock its 29th biggest position. Legacy Advisors LLC's holdings in UnitedHealth Group were worth $5,969,000 at the end of the most recent reporting period.
Several other institutional investors have also bought and sold shares of UNH. NewSquare Capital LLC purchased a new position in UnitedHealth Group during the 4th quarter valued at $25,000. Marshall & Sterling Wealth Advisors Inc. bought a new position in UnitedHealth Group in the fourth quarter worth about $26,000. Hurley Capital LLC purchased a new position in UnitedHealth Group during the 4th quarter worth $28,000. Aster Capital Management DIFC Ltd acquired a new position in UnitedHealth Group during the 4th quarter valued at approximately $30,000. Finally, Promus Capital LLC acquired a new stake in shares of UnitedHealth Group during the fourth quarter worth about $32,000. Institutional investors own 87.86% of the company's stock.
Insiders Place Their Bets
In related news, CEO Patrick Hugh Conway sold 589 shares of the company's stock in a transaction that occurred on Tuesday, June 10th. The shares were sold at an average price of $305.00, for a total transaction of $179,645.00. Following the completion of the transaction, the chief executive officer now owns 10,398 shares of the company's stock, valued at approximately $3,171,390. This represents a 5.36% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, Director Kristen Gil acquired 3,700 shares of the stock in a transaction dated Thursday, May 15th. The shares were bought at an average cost of $271.17 per share, with a total value of $1,003,329.00. Following the completion of the purchase, the director now directly owns 3,818 shares in the company, valued at approximately $1,035,327.06. This trade represents a 3,135.59% increase in their ownership of the stock. The disclosure for this purchase can be found here. In the last three months, insiders bought 109,408 shares of company stock valued at $31,607,768. Company insiders own 0.28% of the company's stock.
UnitedHealth Group Stock Up 1.6%
Shares of UNH stock traded up $4.91 during trading on Tuesday, reaching $305.59. The company's stock had a trading volume of 8,710,041 shares, compared to its average volume of 7,371,930. The stock's 50-day moving average price is $353.44 and its 200 day moving average price is $460.22. The company has a market capitalization of $277.21 billion, a price-to-earnings ratio of 12.80, a P/E/G ratio of 1.42 and a beta of 0.45. The company has a debt-to-equity ratio of 0.71, a current ratio of 0.85 and a quick ratio of 0.85. UnitedHealth Group Incorporated has a 1-year low of $248.88 and a 1-year high of $630.73.
UnitedHealth Group (NYSE:UNH - Get Free Report) last announced its quarterly earnings results on Thursday, April 17th. The healthcare conglomerate reported $7.20 EPS for the quarter, missing the consensus estimate of $7.29 by ($0.09). The company had revenue of $109.58 billion for the quarter, compared to analyst estimates of $111.56 billion. UnitedHealth Group had a return on equity of 26.29% and a net margin of 5.39%. During the same quarter in the prior year, the business earned $6.91 earnings per share. On average, research analysts anticipate that UnitedHealth Group Incorporated will post 29.54 EPS for the current year.
UnitedHealth Group Increases Dividend
The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, June 24th. Investors of record on Monday, June 16th will be paid a dividend of $2.21 per share. This is an increase from UnitedHealth Group's previous quarterly dividend of $2.10. The ex-dividend date is Monday, June 16th. This represents a $8.84 annualized dividend and a dividend yield of 2.89%. UnitedHealth Group's dividend payout ratio is presently 37.02%.
Wall Street Analysts Forecast Growth
Several research firms recently commented on UNH. Argus lowered UnitedHealth Group from a "buy" rating to a "hold" rating in a report on Monday, April 21st. Morgan Stanley lowered their target price on shares of UnitedHealth Group from $563.00 to $374.00 and set an "overweight" rating on the stock in a research note on Wednesday, May 14th. TD Securities reissued a "hold" rating and issued a $308.00 price objective (down from $520.00) on shares of UnitedHealth Group in a report on Monday, May 19th. Erste Group Bank cut shares of UnitedHealth Group from a "strong-buy" rating to a "hold" rating in a research note on Wednesday, April 30th. Finally, Bank of America lowered shares of UnitedHealth Group from a "buy" rating to a "neutral" rating and dropped their target price for the company from $560.00 to $350.00 in a research report on Wednesday, May 14th. One equities research analyst has rated the stock with a sell rating, nine have issued a hold rating and sixteen have given a buy rating to the company. According to data from MarketBeat, the company has a consensus rating of "Moderate Buy" and an average price target of $427.09.
Get Our Latest Stock Report on UNH
About UnitedHealth Group
(
Free Report)
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.
See Also

Before you consider UnitedHealth Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and UnitedHealth Group wasn't on the list.
While UnitedHealth Group currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Which stocks are likely to thrive in today's challenging market? Enter your email address and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.
Get This Free Report